Respiri Limited (RSH.AX)
AUD 0.07
(-4.0%)
AUD 0.07
(-4.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 1.17 Million AUD | 767.0% |
| 2023 | 149.13 Thousand AUD | 111.04% |
| 2022 | 70.66 Thousand AUD | -50.4% |
| 2021 | 142.47 Thousand AUD | -84.04% |
| 2020 | 892.88 Thousand AUD | 10.72% |
| 2019 | 806.44 Thousand AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | -100.0% |
| 2012 | 2896.00 AUD | 0.0% |
| 2011 | - AUD | -100.0% |
| 2010 | 44.94 Thousand AUD | -86.12% |
| 2009 | 323.82 Thousand AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | -100.0% |
| 2002 | 17 Thousand AUD | -37.04% |
| 2001 | 27 Thousand AUD | -60.29% |
| 2000 | 68 Thousand AUD | -62.32% |
| 1999 | 180.46 Thousand AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 1.17 Million AUD | 0.0% |
| 2024 Q2 | 116.39 Thousand AUD | 0.0% |
| 2024 FY | 116.39 Thousand AUD | -21.95% |
| 2023 FY | 149.13 Thousand AUD | 111.04% |
| 2023 Q2 | - AUD | 0.0% |
| 2023 Q4 | 149.13 Thousand AUD | 0.0% |
| 2022 Q2 | 32.39 Thousand AUD | 0.0% |
| 2022 Q4 | 70.66 Thousand AUD | 0.0% |
| 2022 FY | 70.66 Thousand AUD | -50.4% |
| 2021 FY | 142.47 Thousand AUD | -84.04% |
| 2021 Q2 | 144.11 Thousand AUD | 0.0% |
| 2021 Q4 | 142.47 Thousand AUD | 0.0% |
| 2020 FY | 892.88 Thousand AUD | 10.72% |
| 2020 Q4 | 892.88 Thousand AUD | 0.0% |
| 2020 Q2 | 482.31 Thousand AUD | 0.0% |
| 2019 Q4 | 806.44 Thousand AUD | 0.0% |
| 2019 FY | 806.44 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | -100.0% |
| 2013 Q1 | - AUD | -100.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2012 Q4 | 2896.00 AUD | 0.0% |
| 2012 FY | 2896.00 AUD | 0.0% |
| 2011 FY | - AUD | -100.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 FY | 44.94 Thousand AUD | -86.12% |
| 2010 Q4 | 44.94 Thousand AUD | 0.0% |
| 2009 FY | 323.82 Thousand AUD | 0.0% |
| 2009 Q4 | 323.82 Thousand AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2003 FY | - AUD | -100.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2002 FY | 17 Thousand AUD | -37.04% |
| 2002 Q4 | 16.83 Thousand AUD | 0.0% |
| 2001 Q4 | 28.17 Thousand AUD | 0.0% |
| 2001 FY | 27 Thousand AUD | -60.29% |
| 2000 FY | 68 Thousand AUD | -62.32% |
| 1999 FY | 180.46 Thousand AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 77.023% |
| Adherium Limited | 93.2 Thousand AUD | -1162.339% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 82.74% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -1289.587% |
| Anteris Technologies Ltd | 2.33 Million AUD | 49.567% |
| Control Bionics Limited | 961.73 Thousand AUD | -22.337% |
| CardieX Limited | 3.22 Million AUD | 63.549% |
| Compumedics Limited | 6.97 Million AUD | 83.137% |
| Cochlear Limited | 243.7 Million AUD | 99.517% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 65.86% |
| Cyclopharm Limited | 4.22 Million AUD | 72.167% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 59.433% |
| Nova Eye Medical Limited | 3.34 Million AUD | 64.868% |
| HeraMED Limited | 260.65 Thousand AUD | -351.385% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 92.507% |
| ImpediMed Limited | 1.14 Million AUD | -2.936% |
| InhaleRx Limited | 560.27 Thousand AUD | -109.997% |
| LBT Innovations Limited | 1.74 Million AUD | 32.498% |
| Micro-X Limited | 4.05 Million AUD | 70.985% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -1564.822% |
| PolyNovo Limited | 15.38 Million AUD | 92.35% |
| SomnoMed Limited | 1.01 Million AUD | -15.802% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 76.334% |
| Uscom Limited | 989.27 Thousand AUD | -18.931% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | -276.915% |